)
Shenzhen YHLO Biotech (688575) investor relations material
Shenzhen YHLO Biotech Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for H1 2026 reached RMB 887.96 million, up 9.84% year-over-year, driven by domestic demand recovery and international growth.
Net profit attributable to shareholders was RMB 70.13 million, a 166.97% increase year-over-year, with adjusted net profit (excluding non-recurring items) up 46.81%.
Operating cash flow improved significantly to RMB 203.16 million from a negative outflow last year.
Gross margin and profitability improved due to product mix optimization and cost control.
Financial highlights
Operating income: RMB 887.96 million (+9.84% YoY).
Net profit: RMB 70.13 million (+166.97% YoY).
Operating cash flow: RMB 203.16 million (vs. -2.37 million YoY).
Basic and diluted EPS: RMB 0.12 (+140% YoY).
Gross margin for self-produced products: 68.73% (+0.68pp YoY).
Outlook and guidance
Management expects continued growth in both domestic and international markets, with focus on expanding product lines and increasing market penetration.
R&D investment remains a priority to drive innovation and maintain competitive advantage.
- Net profit jumped 76.89% year-over-year, while revenue dipped and overseas sales rose 17.21%.688575
Q1 2026 - Net profit plunged 92.26% on lower revenue and asset impairments, but R&D and overseas sales grew.688575
H2 2025 - Q3 revenue up, profit down on asset losses; overseas business and innovation drive growth.688575
Q3 2025 - Revenue and profit declined sharply, but overseas growth and R&D investment accelerated.688575
H1 2025 - Non-COVID diagnostics and overseas business drove growth despite a sharp profit decline.688575
Q3 2024 - Net profit rose 22.25% on strong non-COVID business despite a 10.69% revenue drop.688575
H1 2024 - Net profit plunged 84.63% year-over-year despite strong overseas growth and product expansion.688575
Q1 2025 - Adjusted net profit surged 31.16% on robust core business and margin improvement.688575
Q4 2024
Next Shenzhen YHLO Biotech earnings date
Next Shenzhen YHLO Biotech earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)